EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSCVAG00000004360
Gene Symbol: GRIK5
3 Cross references
263 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSCVAG00000001025
Gene Symbol: GRM2
3 Cross references
210 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSCVAG00000023051
Gene Symbol: GRM4
3 Cross references
198 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSCVAG00000014517
Gene Symbol: GRM4
3 Cross references
212 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSCVAG00000019046
Gene Symbol: LOC107086317
3 Cross references
252 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSCVAG00000009792
Gene Symbol: LOC107099602
3 Cross references
244 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSCVAG00000008986
Gene Symbol: LOC107081866
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSCVAG00000017539
Gene Symbol: LOC107102417
3 Cross references
203 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSCVAG00000022721
Gene Symbol: LOC107094088
2 Cross references
225 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2c-Like

Ensembl ID : ENSCVAG00000016778
Gene Symbol: LOC107099399
2 Cross references
247 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSCVAG00000022082
Gene Symbol: LOC107089017
2 Cross references
215 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSCVAG00000004543
Gene Symbol: LOC107100309
2 Cross references
213 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).